These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 32493552)
1. Scopolamine Treatment and Adaptation to Airsickness. Doron O; Samuel O; Karfunkel-Doron D; Tal D Aerosp Med Hum Perform; 2020 Apr; 91(4):313-317. PubMed ID: 32493552 [No Abstract] [Full Text] [Related]
2. Prevalence, Predictors, and Prevention of Motion Sickness in Zero-G Parabolic Flights. Golding JF; Paillard AC; Normand H; Besnard S; Denise P Aerosp Med Hum Perform; 2017 Jan; 88(1):3-9. PubMed ID: 28061915 [TBL] [Abstract][Full Text] [Related]
3. Anticholinergic Versus Antihistaminic Treatment for Simulator Sickness Prevention. Ben-Ari O; Sarfati S; Gordon B; Assa A; Nakdimon I J Clin Pharmacol; 2023 Oct; 63(10):1119-1125. PubMed ID: 37491788 [TBL] [Abstract][Full Text] [Related]
4. Airsickness prevention in helicopter passengers. Estrada A; LeDuc PA; Curry IP; Phelps SE; Fuller DR Aviat Space Environ Med; 2007 Apr; 78(4):408-13. PubMed ID: 17484344 [TBL] [Abstract][Full Text] [Related]
5. Motion sickness. Noel P; Norris C J La State Med Soc; 1996 Jan; 148(1):7-11. PubMed ID: 8576633 [TBL] [Abstract][Full Text] [Related]
6. Effect of sickness severity on habituation to repeated motion challenges in aircrew referred for airsickness treatment. Golding JF; Stott JR Aviat Space Environ Med; 1995 Jul; 66(7):625-30. PubMed ID: 7575309 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of low-dose intranasal scopolamine for motion sickness. Simmons RG; Phillips JB; Lojewski RA; Wang Z; Boyd JL; Putcha L Aviat Space Environ Med; 2010 Apr; 81(4):405-12. PubMed ID: 20377145 [TBL] [Abstract][Full Text] [Related]
8. Control of simulator sickness in an AH-64 aviator. Kroll JD Aviat Space Environ Med; 1989 Dec; 60(12):1202-3. PubMed ID: 2604677 [TBL] [Abstract][Full Text] [Related]
9. Predictive efficacy of motion sickness history for airsickness. Lee HL; Chiou WY Zhonghua Yi Xue Za Zhi (Taipei); 2000 Dec; 63(12):893-7. PubMed ID: 11195140 [TBL] [Abstract][Full Text] [Related]
10. The effect of antimotion sickness drugs on habituation to motion. Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377 [TBL] [Abstract][Full Text] [Related]
11. Incidence of airsickness among military parachutists. Antuñano MJ; Hernandez JM Aviat Space Environ Med; 1989 Aug; 60(8):792-7. PubMed ID: 2775137 [TBL] [Abstract][Full Text] [Related]
12. Treatment of motion sickness in parabolic flight with buccal scopolamine. Norfleet WT; Degioanni JJ; Calkins DS; Reschke MF; Bungo MW; Kutyna FA; Homick JL Aviat Space Environ Med; 1992 Jan; 63(1):46-51. PubMed ID: 1550533 [TBL] [Abstract][Full Text] [Related]
13. Motion sickness in cats: a symptom rating scale used in laboratory and flight tests. Suri KB; Crampton GH; Daunton NG Aviat Space Environ Med; 1979 Jun; 50(6):614-8. PubMed ID: 475712 [TBL] [Abstract][Full Text] [Related]
14. Airsickness: Etiology, Treatment, and Clinical Importance-A Review. Samuel O; Tal D Mil Med; 2015 Nov; 180(11):1135-9. PubMed ID: 26540704 [TBL] [Abstract][Full Text] [Related]
16. The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness. Zhang LL; Liu HQ; Yu XH; Zhang Y; Tian JS; Song XR; Han B; Liu AJ CNS Neurosci Ther; 2016 Aug; 22(8):715-22. PubMed ID: 27160425 [TBL] [Abstract][Full Text] [Related]